← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2010Last known activity
Dec 30, 2024
Timeline
1990s
- Jun 1, 1999
Fundación Pública Andaluza— Founded
Drugs by trial phase (71 distinct, 37 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (27 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Atrial Fibrillation
- Autoimmune Diseases
- Autoimmune Diseases of the Nervous System
- Bacteremia
- Brain Diseases
- Breast Neoplasms
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Colitis, Ulcerative
- Communicable Diseases
- Critical Illness
- Crohn Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Embolism
- Endocarditis
- Endocarditis, Bacterial
- Endocarditis, Subacute Bacterial
- Enterobacteriaceae Infections
- Fibrosis
- Fractures, Bone
- Graft vs Host Disease
- Heart Failure
- Hepatic Encephalopathy
- Hepatitis
- Hepatitis B
- Hip Fractures
- HIV Infections
- Idiopathic Pulmonary Fibrosis
- Infections
- Intellectual Disability
- Latent Tuberculosis
- Liver Cirrhosis
- Mental Disorders
- Multiple Myeloma
- Multiple Sclerosis
- Nervous System Diseases
- Pneumonia
- Pneumonia, Bacterial
- Pseudomonas Infections
- Psychotic Disorders
- Pulmonary Embolism
- Pulmonary Fibrosis
- Respiration Disorders
- Respiratory Tract Diseases
- Sclerosis
- Syndrome
- Thromboembolism
- Thrombosis
- Tuberculosis
- Venous Thrombosis
Recent trials (41)
- NCT06598969Lead sponsorPhase 2Dec 30, 2024
- NCT06423898Lead sponsorPhase 4Oct 9, 2024
- NCT06602323Lead sponsorPhase 2Oct 1, 2024
- NCT05982275Lead sponsorPhase 1/Phase 2Jan 30, 2024
- NCT05913245Lead sponsorN/AMar 30, 2023
- NCT05913245Study chairN/AMar 30, 2023
- NCT05913245Reponsible party - principal investigatorN/AMar 30, 2023
- NCT05325593Lead sponsorPhase 3Dec 2, 2022
- NCT05207280Lead sponsorPhase 3May 31, 2022
- NCT05225961Lead sponsorPhase 4May 1, 2022
- NCT04478734Lead sponsorPhase 2Jan 1, 2022
- NCT05095649Lead sponsorPhase 2Dec 15, 2021
- NCT04895488Overall official - principal investigatorPhase 2/Phase 3Nov 15, 2021
- NCT04895488Lead sponsorPhase 2/Phase 3Nov 15, 2021
- NCT04710199Lead sponsorPhase 2Feb 23, 2021
Details
- Founded
- Seville, ES Jun 1, 1999
- Last known activity
- Dec 30, 2024